4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole

C17H21N5O3 — CID 146275155

IUPAC4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole
SMILESCOC1CN(C2=CCN(Cc3c(-c4cc(C)on4)noc3C)N=C2)C1
InChIInChI=1S/C17H21N5O3/c1-11-6-16(19-24-11)17-15(12(2)25-20-17)10-22-5-4-13(7-18-22)21-8-14(9-21)23-3/h4,6-7,14H,5,8-10H2,1-3H3
InChIKeyCQBXDHCFJNHPQY-UHFFFAOYSA-N
MW343.39 g/mol
LogP1.96
Rot. Bonds5

About 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole

4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole (PubChem CID 146275155) has the molecular formula C17H21N5O3 and a molecular weight of 343.39 g/mol. Its IUPAC name is 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole.

Molecular Properties

Compound Name4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole
PubChem CID146275155
Molecular FormulaC17H21N5O3
Molecular Weight343.39 g/mol
Exact Mass343.16
IUPAC Name4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole
SMILESCOC1CN(C2=CCN(Cc3c(-c4cc(C)on4)noc3C)N=C2)C1
InChIInChI=1S/C17H21N5O3/c1-11-6-16(19-24-11)17-15(12(2)25-20-17)10-22-5-4-13(7-18-22)21-8-14(9-21)23-3/h4,6-7,14H,5,8-10H2,1-3H3
InChIKeyCQBXDHCFJNHPQY-UHFFFAOYSA-N
XLogP1.96
TPSA80.13 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500343.39
LogP ≤ 51.96
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole?
The IUPAC name of 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole (CID 146275155) is 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole.
What is the SMILES notation for 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole?
The canonical SMILES for 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole is COC1CN(C2=CCN(Cc3c(-c4cc(C)on4)noc3C)N=C2)C1.
What is the InChIKey of 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole?
The InChIKey is CQBXDHCFJNHPQY-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H21N5O3/c1-11-6-16(19-24-11)17-15(12(2)25-20-17)10-22-5-4-13(7-18-22)21-8-14(9-21)23-3/h4,6-7,14H,5,8-10H2,1-3H3.
What are the key properties of 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole?
4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole has a molecular weight of 343.39 g/mol, XLogP of 1.96, 5 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[5-(3-methoxyazetidin-1-yl)-3H-pyridazin-2-yl]methyl]-5-methyl-3-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole is sourced from PubChem (CID 146275155), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).